Further investigation revealed that miR-19b-1 could inhibit de novo lipogenesis in CRC cells by limiting the FA-activating enzymes (ACSLs and SCD), leading to a significant reduction in cell invasion [40]. This evidence concerns the gene SCD and colorectal carcinoma.